Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

89Bio Inc (ETNB)

89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,057,496
  • Shares Outstanding, K 93,501
  • Annual Sales, $ 0 K
  • Annual Income, $ -142,190 K
  • 60-Month Beta 1.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.97
Trade ETNB with:

Options Overview Details

View History
  • Implied Volatility 69.08% ( +0.43%)
  • Historical Volatility 81.88%
  • IV Percentile 41%
  • IV Rank 10.33%
  • IV High 221.57% on 09/29/23
  • IV Low 51.52% on 06/21/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 159
  • Volume Avg (30-Day) 732
  • Put/Call OI Ratio 1.68
  • Today's Open Interest 21,566
  • Open Int (30-Day) 22,227

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.48
  • Number of Estimates 4
  • High Estimate -0.42
  • Low Estimate -0.57
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.00 +5.82%
on 03/27/24
16.63 -30.01%
on 03/04/24
-0.12 (-1.02%)
since 02/28/24
3-Month
7.47 +55.82%
on 02/06/24
16.63 -30.01%
on 03/04/24
+0.30 (+2.65%)
since 12/28/23
52-Week
6.57 +77.03%
on 10/23/23
22.93 -49.24%
on 06/13/23
-5.05 (-30.26%)
since 03/28/23

Most Recent Stories

More News
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 2.39 (-0.83%)
GLMD : 0.3463 (+4.88%)
VKTX : 82.00 (-1.61%)
ETNB : 11.64 (+2.92%)
IVA : 3.62 (-5.24%)
SGMT : 5.42 (-5.41%)
TERN : 6.56 (+6.49%)
NVO : 128.40 (+0.27%)
IQV : 252.89 (+0.13%)
MDGL : 267.04 (+3.18%)
Why Shares of 89bio Plummeted on Tuesday

So-so trial data for a competitor's NASH therapy candidate that is similar to 89bio's candidate spooked investors.

AKRO : 25.26 (+3.31%)
ETNB : 11.64 (+2.92%)
Why Akero Therapeutics Stock Is Crashing Today

Investors are bailing on the biotech stock after disappointing clinical results for experimental NASH drug efruxifermin (EFX).

ETNB : 11.64 (+2.92%)
AKRO : 25.26 (+3.31%)
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data, Powell Speech

September S&P 500 futures (ESU23) are down -0.12%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.22% this morning as market participants looked ahead to the release of the Fed’s favorite...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 175.79 (-2.25%)
NVDA : 903.56 (+0.12%)
JD : 27.39 (+0.59%)
PDD : 116.25 (-0.35%)
KMX : 87.11 (+0.15%)
DBK.D.DX : 14.600 (+0.10%)
AML.LN : 169.900 (-2.07%)
MLTX : 50.23 (+0.04%)
ETNB : 11.64 (+2.92%)
GOOGL : 150.93 (+0.04%)
Wall Street Analysts Predict a 57.05% Upside in 89BIO (ETNB): Here's What You Should Know

The mean of analysts' price targets for 89BIO (ETNB) points to a 57.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...

ETNB : 11.64 (+2.92%)
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?

Here is how Allogene Therapeutics (ALLO) and 89BIO (ETNB) have performed compared to their sector so far this year.

ALLO : 4.47 (+0.22%)
ETNB : 11.64 (+2.92%)
Ultragenyx (RARE) Q1 Earnings and Revenues Miss Estimates

Ultragenyx Pharmaceutical's (RARE) first-quarter 2023 earnings and revenues miss estimates. The company maintains its 2023 guidance.

REGN : 962.49 (-0.39%)
RARE : 46.69 (-0.28%)
APTX : 0.0960 (+3.11%)
ETNB : 11.64 (+2.92%)
3 Biotech Buyout Targets to Watch

The trio all have late-stage therapies with blockbuster potential.

ETNB : 11.64 (+2.92%)
KRTX : 329.83 (+0.03%)
MORF : 35.20 (+2.36%)
Is 89BIO (ETNB) Outperforming Other Medical Stocks This Year?

Here is how 89BIO (ETNB) and Henry Schein (HSIC) have performed compared to their sector so far this year.

ETNB : 11.64 (+2.92%)
HSIC : 75.52 (+0.49%)
Why Shares of 89bio Soared This Week

The company released positive results for its lead therapy.

ETNB : 11.64 (+2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis....

See More

Key Turning Points

3rd Resistance Point 12.56
2nd Resistance Point 12.13
1st Resistance Point 11.88
Last Price 11.64
1st Support Level 11.20
2nd Support Level 10.77
3rd Support Level 10.52

See More

52-Week High 22.93
Fibonacci 61.8% 16.68
Fibonacci 50% 14.75
Fibonacci 38.2% 12.82
Last Price 11.64
52-Week Low 6.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar